Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06517602
NCT06517602
Completed
Not Applicable

Effect of Daily Consumption of Moringa Oleifera Leaves on Glycemic Control of Saharawi Women With Type 2 Diabetes

University of Milan1 site in 1 country52 target enrollmentStarted: November 7, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Status
Completed
Enrollment
52
Locations
1
Primary Endpoint
Fasting glucose
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

The objective of this clinical trial was to understand whether supplementation of Moringa oleifera leaf powder improved glycemic management in Sahrawi women with type 2 diabetes living in refugee camps. The main question sought to be answered was:

  • Does daily supplementation of Moringa oleifera leaf powder, in addition to oral hypoglycemic therapy, improve glycosylated hemoglobin and fasting blood glucose?

Researchers compared Moringa supplementation with no Moringa consumption to see if Moringa oleifera worked to improve glycemic control.

Participants had to:

  • Take Moringa oleifera leaves daily or abstain from consuming Moringa for 3 months.
  • Consistently take prescribed oral hypoglycemic agents
  • Undergo clinical examinations and measurement of biochemical, metabolic and body composition parameters at the time of recruitment and at the end of the study.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of type 2 diabetes for at least 1 year
  • •Absence of advanced retinopathy, terminal renal failure, active diabetic ulcers, amputations, and heart failure
  • •Treatment with only oral hypoglycemic drugs.

Exclusion Criteria

  • •Diagnosis of type 1 diabetes
  • •Pregnancy or lactation
  • •Treatment with insulin.

Outcomes

Primary Outcomes

Fasting glucose

Time Frame: Fasting glucose was measured at recruitment and at the end of the study (three months)

Glycosylated hemoglobin (HbA1c)

Time Frame: Glycosylated hemoglobin was measured at recruitment and at the end of the study (three months)

Secondary Outcomes

  • Hip circumference(Hip circumference were measured at recruitment and at the end of the study (3 months))
  • BMI(BMI were measured at recruitment and at the end of the study (3 months))
  • Waist circumference(Waist circumference were measured at recruitment and at the end of the study (3 months))
  • % body fat(% of body fat were measured at recruitment and at the end of the study (3 months))
  • Blood pressure(Systolic and diastolic blood pressure were measured at recruitment and at the end of the study (3 months))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alberto Battezzati

Professor

University of Milan

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Effect of Moringa Oleifera Infusion on HealthMetabolic Syndrome
NCT04314258University of Mauritius103
Completed
Not Applicable
Moringa Supplementation for Improved Milk OutputBreastfeeding
NCT05333939University of Kentucky41
Completed
Not Applicable
Effect of consecutive ingestion of Moringa oleifera leaves on improving constipation.Healthy adult female with a tendency for constipation
JPRN-UMIN000024674Wayo Women's University40
Not yet recruiting
Not Applicable
Effect of nutritional supplementation of Moringa oleifera on immune response in gum disease in humansHealth Condition 1: K053- Chronic periodontitis
CTRI/2022/02/040594MGM Institute of Health Sciences
Completed
Phase 3
Effects of Moringa oleifera leaf powder supplementation in pregnant mothers on maternal and birth outcomes.
ACTRN12618001661268Prof. Veni Hadju20